Islet Transplantation Using Donors After Cardiac Death: Report of the Japan Islet Transplantation Registry
- 15 October 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 90 (7), 740-747
- https://doi.org/10.1097/tp.0b013e3181ecb044
Abstract
This report summarizes outcomes of islet transplantation employing donors after cardiac death (DCD) between 2004 and 2007 as reported to the Japan Islet Transplantation Registry. Sixty-five islet isolations were performed for 34 transplantations in 18 patients with insulin-dependent diabetes mellitus, including two patients who had prior kidney transplantation. All but one donor (64/65) was DCD at the time of harvesting. Factors influencing criteria for islet release included duration of low blood pressure of the donor, cold ischemic time, and usage of Kyoto solution for preservation. Multivariate analysis selected usage of Kyoto solution as most important. Of the 18 recipients, 8, 4, and 6 recipients received 1, 2, and 3 islet infusions, respectively. Overall graft survival defined as C-peptide level more than or equal to 0.3 ng/mL was 76.5%, 47.1%, and 33.6% at 1, 2, and 3 years, respectively, whereas corresponding graft survival after multiple transplantations was 100%, 80.0%, and 57.1%, respectively. All recipients remained free of severe hypoglycemia while three achieved insulin independence for 14, 79, and 215 days. HbA1c levels and requirement of exogenous insulin were significantly improved in all patients. Islet transplantation employing DCD can ameliorate severe hypoglycemic episodes, significantly improve HbA1c levels, sustain significant levels of C-peptide, and achieve insulin independence after multiple transplantations. Thus, DCD can be an important resource for islet transplantation if used under strict releasing criteria and in multiple transplantations, particularly in countries where heart-beating donors are not readily available.Keywords
This publication has 36 references indexed in Scilit:
- 2008 Update From the Collaborative Islet Transplant RegistryTransplantation, 2008
- Low Risk of Anti-Human Leukocyte Antigen Antibody Sensitization After Combined Kidney and Islet TransplantationTransplantation, 2008
- Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell TransplantationPLOS ONE, 2008
- No Beneficial Effect of Two-Layer Storage Compared With UW-Storage on Human Islet Isolation and TransplantationTransplantation, 2007
- Human Islets Derived From Donors After Cardiac Death Are Fully BiofunctionalAmerican Journal of Transplantation, 2007
- Follow-up Study of the First Successful Living Donor Islet TransplantationTransplantation, 2006
- Successful Islet Transplantation from Nonheartbeating Donor Pancreata Using Modified Ricordi Islet Isolation MethodTransplantation, 2006
- Resolution of Neurotoxicity and β-Cell Toxicity in an Islet Transplant Recipient following Substitution of Tacrolimus with MMFCell Transplantation, 2006
- Procurement of the Human Pancreas for Pancreatic Islet Transplantation from Marginal Cadaver DonorsTransplantation, 2006
- Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs)Journal of Hepato-Biliary-Pancreatic Surgery, 2005